Marex Group’s Idexx Laboratories IDXX Stock Holding History

Marex Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-350	Closed	-$237K	–	1140
2025 Q4	$237K	Buy	+350	New	+$238K	﹤0.01%	791
2025 Q3	–	Sell	-577	Closed	-$309K	–	923
2025 Q2	$309K	Sell	577 -179	-24%	-$85.6K	﹤0.01%	442
2025 Q1	$317K	Sell	756 -275	-27%	-$119K	0.01%	440
2024 Q4	$426K	Buy	+1,031	New	+$452K	0.01%	376
2024 Q3	–	Sell	-22,000	Closed	-$10.7M	–	701
2024 Q2	$10.7M	Buy	+22,000	New	+$11M	0.29%	62

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marex Group's IDXX Position: Q1 2026 in Review

Marex Group sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 350 shares — an estimated $237K sold.

Marex Group first reported a position in IDXX in Q2 2024 and held it in 5 quarters. The position peaked at $10.7M in Q2 2024. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Marex Group reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Marex Group sold 350 Idexx Laboratories shares in Q1 2026, an estimated $237K.
Marex Group first reported a position in Idexx Laboratories in Q2 2024 and held it in 5 quarters.
Marex Group's Idexx Laboratories position peaked at $10.7M in Q2 2024.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.